Expression and release of intercellular adhesion molecule-1 in renal-cancer patients

This publication has 18 references indexed in Scilit:

• Soluble intercellular adhesion molecule—1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts
  European Journal Of Cancer, 1994
• Expression and shedding of ICAM‐1 in bladder cancer and its immunotherapy
  International Journal of Cancer, 1993
• Circulating adhesion molecules in disease
  Immunology Today, 1993
• Activation of cytolytic activity in peripheral blood
  International Journal of Cancer, 1993
• Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
  British Journal of Cancer, 1993
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
  Proceedings of the National Academy of Sciences, 1989
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
  The Journal of Experimental Medicine, 1988
• Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicity
  European Journal of Immunology, 1988
• LFA-1, LFA-3, AND ICAM-1 EXPRESSION IN BURKITT'S LYMPHOMA
  The Lancet, 1987
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958